220 related articles for article (PubMed ID: 36418470)
1. CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype.
Zeng W; Xiong L; Wu W; Li S; Liu J; Yang L; Lao L; Huang P; Zhang M; Chen H; Miao N; Lin Z; Liu Z; Yang X; Wang J; Wang P; Song E; Yao Y; Nie Y; Chen J; Huang D
Oncogene; 2023 Jan; 42(3):224-237. PubMed ID: 36418470
[TBL] [Abstract][Full Text] [Related]
2. CD10
Su S; Chen J; Yao H; Liu J; Yu S; Lao L; Wang M; Luo M; Xing Y; Chen F; Huang D; Zhao J; Yang L; Liao D; Su F; Li M; Liu Q; Song E
Cell; 2018 Feb; 172(4):841-856.e16. PubMed ID: 29395328
[TBL] [Abstract][Full Text] [Related]
3. FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer.
Zhao Z; Zhu Y
BMC Cancer; 2023 Jun; 23(1):507. PubMed ID: 37277751
[TBL] [Abstract][Full Text] [Related]
4. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
[TBL] [Abstract][Full Text] [Related]
5. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.
Chen J; Yao Y; Gong C; Yu F; Su S; Chen J; Liu B; Deng H; Wang F; Lin L; Yao H; Su F; Anderson KS; Liu Q; Ewen ME; Yao X; Song E
Cancer Cell; 2011 Apr; 19(4):541-55. PubMed ID: 21481794
[TBL] [Abstract][Full Text] [Related]
6. CCL18 in the Progression of Cancer.
Korbecki J; Olbromski M; Dzięgiel P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114763
[TBL] [Abstract][Full Text] [Related]
7. High expressions of CD10, FAP and GPR77 in CAFs are associated with chemoresistance and worse prognosis in gastric cancer.
Tong Y; Zhao Z; Zhang J; Wang W; Zhu Y
Front Oncol; 2022; 12():984817. PubMed ID: 36387219
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
9. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
10. Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway.
Chandra Jena B; Kanta Das C; Banerjee I; Das S; Bharadwaj D; Majumder R; Mandal M
Biochem Pharmacol; 2021 Apr; 186():114474. PubMed ID: 33607074
[TBL] [Abstract][Full Text] [Related]
11. CD10
Cancer Discov; 2018 Mar; 8(3):264. PubMed ID: 29420180
[TBL] [Abstract][Full Text] [Related]
12. Discovery of CCL18 antagonist blocking breast cancer metastasis.
Liu Y; Zheng H; Li Q; Li S; Lai H; Song E; Li D; Chen J
Clin Exp Metastasis; 2019 Jun; 36(3):243-255. PubMed ID: 31062206
[TBL] [Abstract][Full Text] [Related]
13. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
[TBL] [Abstract][Full Text] [Related]
14. A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.
Yu S; Lu Y; Su A; Chen J; Li J; Zhou B; Liu X; Xia Q; Li Y; Li J; Huang M; Ye Y; Zhao Q; Jiang S; Yan X; Wang X; Di C; Pan J; Su S
Adv Sci (Weinh); 2021 Oct; 8(19):e2101848. PubMed ID: 34363355
[TBL] [Abstract][Full Text] [Related]
15. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
Jena BC; Das CK; Bharadwaj D; Mandal M
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
[TBL] [Abstract][Full Text] [Related]
16. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
Yoshida GJ
J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
[TBL] [Abstract][Full Text] [Related]
17. Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer.
Peng Q; Zhao L; Hou Y; Sun Y; Wang L; Luo H; Peng H; Liu M
PLoS One; 2013; 8(4):e60321. PubMed ID: 23577100
[TBL] [Abstract][Full Text] [Related]
18. CCL18/PITPNM3 enhances migration, invasion, and EMT through the NF-κB signaling pathway in hepatocellular carcinoma.
Lin Z; Li W; Zhang H; Wu W; Peng Y; Zeng Y; Wan Y; Wang J; Ouyang N
Tumour Biol; 2016 Mar; 37(3):3461-8. PubMed ID: 26449829
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts mediated chemoresistance by a FOXO1/TGFβ1 signaling loop in esophageal squamous cell carcinoma.
Zhang H; Xie C; Yue J; Jiang Z; Zhou R; Xie R; Wang Y; Wu S
Mol Carcinog; 2017 Mar; 56(3):1150-1163. PubMed ID: 27769097
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
